In contrast, AFP and PIVKA-II levels showed no statistical differences between the CHB and LC groups, and AFP levels were not notably high across the groups, with a median of only 10.5 ng/ml in the HBV-HCC group, much lower than the guideline-recommended 400 ng/ml (10). The gene discussed is AFP; the disease is hepatocellular carcinoma.